Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 21, 2012; 18(27): 3610-3616
Published online Jul 21, 2012. doi: 10.3748/wjg.v18.i27.3610
Published online Jul 21, 2012. doi: 10.3748/wjg.v18.i27.3610
Clinicopathological factors | Tumor without lymphovascular invasion | Tumor with lymphovascular invasion | P value |
Patients | 314 | 122 | |
Age (yr) | 58.95 ± 11.88 | 58.84 ± 10.66 | 0.927 |
Sex | |||
Male | 235 (74.8) | 85 (69.7) | 0.279 |
Female | 79 (25.2) | 37 (30.3) | |
Tumor location | |||
Upper | 110 (35.0) | 42 (34.4) | 0.733 |
Middle | 57 (18.2) | 20 (16.4) | |
Lower | 140 (44.6) | 55 (45.1) | |
Whole | 7 (2.2) | 5 (4.1) | |
Resection type | |||
Subtotal | 236 (75.2) | 87 (71.3) | 0.465 |
Total | 78 (24.8 | 35 (28.7) | |
Tumor size (cm) | |||
< 5 cm | 206 (65.6) | 82 (67.2) | 0.822 |
≥ 5 cm | 108 (34.4) | 40 (32.8) | |
Histological type | |||
Differentiated | 123 (39.2) | 54 (44.3) | 0.331 |
Undifferentiated | 191 (60.8) | 68 (55.7) | |
No. of retrieved LNs | 21.5 ± 5.5 | 22.3 ± 7.0 | 0.248 |
LN | |||
Positive | 96 (30.6) | 51 (41.8) | 0.032 |
Negtive | 218 (69.4) | 71 (58.2) | |
Stage | < 0.001 | ||
IIa | 264 (84.1) | 70 (57.4) | |
IIb | 50 (15.9) | 52 (42.6) | |
Survival at 5 yr (%) | 39.6 | 54.8 | 0.006 |
Group I (LBVI-/LN-) | Group II (LBVI+/LN-) | Group III (LBVI-/LN+) | Group IV (LBVI+/LN+) | P value | |
Patients | 218 | 51 | 96 | 71 | |
Age (yr) | 59.7 ± 11.5 | 59.4 ± 9.1 | 57.3 ± 12.6 | 58.4 ± 11.7 | 0.367 |
Male:female | 3.36 | 1.68 | 2.31 | 2.94 | 0.160 |
Tumor location | |||||
Upper | 79 (36.2) | 17 (33.3) | 31 (32.3) | 25 (35.2) | 0.959 |
Middle | 39 (17.9) | 8 (15.7) | 18 (18.8) | 12 (16.9) | |
Lower | 96 (44.0) | 23 (45.1) | 44 (45.8) | 32 (45.1) | |
Whole | 4 (1.8) | 3 (5.9) | 3 (3.1) | 2 (2.8) | |
Tumor size | |||||
≤ 5 cm | 141 (64.7) | 35 (68.6) | 65 (67.7) | 47 (66.2) | 0.929 |
> 5 cm | 77 (35.3) | 16 (31.4) | 31 (32.3) | 24 (33.8) | |
No. of retrieved LNs | 21.2 ± 5.7 | 22.1 ± 8.0 | 22.0 ± 5.0 | 22.45 ± 6.2 | 0.413 |
Histological type | |||||
Differentiated | 85 (39.0) | 22 (43.1) | 38 (39.6) | 32 (45.1) | 0.801 |
Undifferentiated | 133 (61.0) | 29 (56.9) | 58 (60.4) | 39 (59.4) | |
Resection type | |||||
Subtotal | 167 (76.6) | 33 (64.7) | 69 (71.9) | 54 (76.1) | 0.328 |
Total | 51 (23.4) | 18 (35.3) | 27 (28.1) | 17 (23.9) | |
5-year overall survival (%) | 58.8 | 45.8 | 45.7 | 36.9 | 0.009 |
- Citation: Du CY, Chen JG, Zhou Y, Zhao GF, Fu H, Zhou XK, Shi YQ. Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer. World J Gastroenterol 2012; 18(27): 3610-3616
- URL: https://www.wjgnet.com/1007-9327/full/v18/i27/3610.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i27.3610